David Roblin

David Roblin, CEO of Relation Therapeutics, delves into the revolutionary use of multi-omic tools and machine learning in drug discovery. He discusses the power of collaboration within London's biotech scene and shares insights from his journey from clinical medicine to the pharmaceutical industry. Roblin highlights the importance of teamwork, the impact of non-coding DNA on disease understanding, and how AI integration is transforming drug development. His fascinating perspective on interdisciplinary science and partnerships offers a glimpse into the future of biopharma innovation.